The author(s) received no specific funding for this work (Thanks to UL ID for collaborating with us!)
The intersection of increased chronic disease burden worldwide with the COVID-19 pandemic was called the “perfect storm”. This article discusses yet another perfect storm: Post COVID-19 (acute and non-acute) syndrome, high chronic disease burdens, advanced age, and polypharmacy. The expected hyper polypharmacy that should result from the added disease and symptom burden due to post COVID-19 syndrome is discussed, as well as the importance of studying the incidence and characteristics to be able to address avoidable medication-related problems.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
"Post-Acute Sequelae of COVID-19 and Polypharmacy: If You Think There’s Too Much Polypharmacy Now, Just Wait,"
The University of Louisville Journal of Respiratory Infections: Vol. 5
, Article 19.
Available at: https://ir.library.louisville.edu/jri/vol5/iss1/19